Results
NATCO Pharma Q4 PAT Rises 32.9% with One-Time Tax Benefit
NATCO Pharma reported Q4FY26 total revenue of INR 8,169 Mn and a net profit of INR 2,690 Mn, which includes a one-time tax benefit of INR 1,150 Mn.
The company launched key products including generic
